ATLASATLAS fair value
₹3,570
Close to fair value · 3% premium
Range: ₹2,382–₹5,351Fair valuePrice
Pfizer (PFIZER.NSE)
Pfizer share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - General · National Stock Exchange of India · India
₹3,687▲ +2.07%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
52%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Pfizer in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Pfizer
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Pfizer's fair value at about ₹3,570 per share (reasonable range: ₹2,382 to ₹5,351). At ₹3,687, the stock trades within 8% of that figure: close to fair value.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Pfizer a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹3,537 and ₹3,867; in 9 out of 10, between ₹3,269 and ₹4,184. Estimated annual volatility is 26%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹174B
- Market cap (USD)
- $1.8B
- P/E ratio
- 22.9
- Dividend yield
- 8.15%
- 52-week high
- ₹5,346
- 52-week low
- ₹3,589
- Revenue (12 months)
- ₹25.7B
- Operating margin
- 35.7%
- Net margin
- 28.6%
- Beta
- 0.13
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Pfizer sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks PFIZER.NSE has traded between ₹3,589 and ₹5,346. Today it is 31.0% below that high and 3% above its low.
On the business: net margin is 28.6%; it trades at 22.9 times earnings.
Its beta is 0.13: it tends to move less than the market.
About the company
Pfizer Ltd., a key player in the pharmaceutical and biotechnology industry, is renowned for its development, manufacturing, and distribution of a broad range of healthcare products.
Want to see everything about Pfizer?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Pfizer (PFIZER.NSE) fair value?
About ₹3,570 per share according to ATLAS (reasonable range: ₹2,382 to ₹5,351). With the stock at ₹3,687, it is close to that value.
What is the chance PFIZER.NSE goes up next month?
52%: close to a coin flip. In half of the simulated outcomes, PFIZER.NSE ends the month between ₹3,537 and ₹3,867.
How big is Pfizer and what is its P/E ratio?
Pfizer's market capitalization is ₹174B. Its price-to-earnings (P/E) ratio is 22.9: you pay ₹22.9 for each ₹1.00 of yearly earnings.
Does Pfizer pay a dividend?
Yes. PFIZER.NSE's current dividend yield is 8.15% at today's price (₹3,687).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer